mumps virus vaccine

mumps vi·rus vac·cine

vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures. See: measles, mumps, and rubella vaccine.
References in periodicals archive ?
In 1967, a live, attenuated mumps virus vaccine was licensed in the United States, and by 2005 high coverage with 2 doses among children had reduced the incidence of mumps by 99% (2).
Also, routine vaccination with two doses of a live mumps virus vaccine is recommended for health care workers born during or after 1957 without other evidence of immunity.
In the specially convened meeting--the results of which are considered interim-the committee redefined evidence of immunity to mumps through vaccination as follows: one dose of a live mumps virus vaccine for preschool children and adults not at high risk; two doses for children in grades kindergarten through 12 and adults at high risk (such as persons who work in health care facilities, international travelers, and students at post-high school educational institutions).
Practitioners should ensure that preschool children and adults not at high risk have had one dose of a live mumps virus vaccine, and that two doses have been given for children in grades K-12 and adults at high risk (for example, persons who work in health care facilities, international travelers, and students at post--high school educational institutions).
Key changes to 1998 ACIP recommendations on mumps--May 17, 2006 Acceptable Presumptive Evidence of Immunity * Documentation of adequate vaccination is now 2 doses of a live mumps virus vaccine instead of 1 dose for -- School-aged children (i.
Evidence of immunity through documentation of adequate vaccination is now defined as 1 dose of a live mumps virus vaccine for preschool-aged children and adults not at high risk and 2 doses for school-aged children (i.
Because birth before 1957 is only presumptive evidence of immunity, healthcare facilities should consider recommending 1 dose of a live mumps virus vaccine for unvaccinated workers born before 1957 who do not have a history of physician-diagnosed mumps or laboratory evidence of mumps immunity.
In a specially convened meeting on May 17, 2006, ACIP redefined evidence of immunity to mumps through vaccination as follows: 1 dose of a live mumps virus vaccine ** for preschool children and adults not at high risk; 2 doses for children in grades K-12 and adults at high risk (i.